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Endothelial dysfunction as a modifier of angiogenic response in
Zucker diabetic fat rat: Amelioration with Ebselen.
Background. Progression of nephropathy in metabolic syn-
drome is associated with microvasculopathy and vascular
dropout.
Methods. Eight- and 22-week-old Zucker diabetic fat (ZDF)
and Zucker lean (ZL) rats were studied to characterize the pro-
gression of nephropathy, and to test the effect of a peroxynitrite
scavenger, Ebselen, on renal microvasculature and angiogenic
competence.
Results. Capillary density was increased, both in the cortex
(P < 0.05) and in the inner medulla (P < 0.001) by the age of
8 weeks, but significantly decreased (P < 0.01 and P < 0.001) by
the age of 22 weeks in ZDF compared to ZL rats. Similarly, the
angiogenic competence of cortical and medullary renal explants
was increased in 8-week-old ZDF (P < 0.01), but decreased at
22 weeks (P < 0.001). Alterations of angiogenic competence
in ZDF rats were associated with altered expression of vascu-
lar endothelial growth factor (VEGF), reduced expression of
Flk-1, and neuropilin. Acetylcholine-induced relaxation of mi-
crodissected interlobar arteries from 8-week-old ZDF rats was
unimpaired, but significantly attenuated in 22-week-old ZDF
rats (P < 0.001). Treatment with Ebselen partially prevented
the decrease in capillary density and angiogenic competence of
renal explants, and restored acetylcholine-induced vasorelax-
ation in 22-week-old ZDF rats.
Conclusion. The progression of nephropathy in ZDF rats is
associated with decreased angiogenic competence both ex vivo
and in vivo. This is accompanied by a altered expression of
VEGF system components and endothelial dysfunction, and
scavenging peroxynitrite with Ebselen ameliorates the progres-
sion of microvasculopathy and partially restores angiogenesis.
These findings reveal the complex mechanism of microvascular
dropout in experimental metabolic syndrome.
Plasticity and adaptability of the microvasculature un-
der physiologic or pathologic stress is engendered in part
Key words: metabolic syndrome, VEGF, angiogenesis, nephropathy.
Received for publication November 28, 2003
and in revised form March 4, 2004, and May 27, 2004
Accepted for publication June 29, 2004
C© 2004 by the International Society of Nephrology
in the angiogenic competence of endothelial cells, allow-
ing them to meet the ever-changing requirements for
tissue perfusion and oxygenation. Therefore, the mecha-
nisms of angiogenesis have been thoroughly investigated
(reviewed in [1–3]). Studies from several laboratories, in-
cluding our previous work, have demonstrated that an-
giogenic cues, although necessary, alone are insufficient
to guide angiogenesis [4–6]. Functional vascular endothe-
lium, specifically the activity of nitric oxide synthase, is
a consistent prerequisite for the proper angiogenic re-
sponse [7].
Remodeling of the microvascular network takes place
under a variety of pathophysiologic conditions, includ-
ing renal diseases. It was originally noted more than 4
decades ago, and confirmed recently by several investiga-
tive groups, that tubulointerstitial fibrosis in progressive
renal diseases proceeds hand-in-hand with the rarefac-
tion of peritubular capillary networks [8–13]. The degree
of vascularization was found to be significantly decreased;
this single parameter had the highest predictive value
for the development of renal dysfunction [10] (it is not
known, however, which element of this pathologic part-
nership is the primary cause and which is the conse-
quence).
Progressive nephropathy in metabolic syndrome, a dis-
ease of epidemic proportions [14, 15], has been well
documented (reviewed in [16]). Studies performed in
a model of metabolic syndrome and insulin resistance
using Zucker diabetic fatty rats (fa/fa) showed that
podocyte injury promotes the progression of focal seg-
mental glomerulosclerosis [17].
Our previous studies of endothelial cells subjected to
an advanced glycation end products (AGE)-modified
long-lived extracellular matrix protein, glycated collagen
I, revealed the development of premature senescence of
these cells, which was found to be prevented and reversed
by the administration of a bona fide peroxynitrite scav-
enger/antioxidant, Ebselen [18, 19]. This seleno-organic
compound [20] is well tolerated by experimental ani-
mals and humans. Indeed, previous studies have also im-
plicated an increased formation of peroxynitrite in the
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development of vasculopathy and in the aging process
[21–23]. These findings prompted us to investigate the
angiogenic competence of endothelial cells in a model of
the metabolic syndrome with type 2 diabetes—Zucker
diabetic rats and the effect of Ebselen on the above pa-
rameters.
METHODS
Experimental animals
Studies were carried out on Zucker diabetic fatty
(ZDF) and nondiabetic lean control (ZL) rats (Charles
River Laboratories) aged 8 and 22 weeks. The animals
were housed in animal quarters kept at 20 to 22◦C with
a 12-hour light/dark cycle, and were allowed free access
to rat-chow and water throughout the study. ZDF rats
were randomly divided into the following groups. The
first group was treated daily with Ebselen administered
by gavage in two doses of 5 mg/kg body weight each
(Daiichi Corporation, Tokyo, Japan) dissolved in 5%
CM-Cellulose (Sigma, St. Louis, MO, USA) starting at
the age of 9 weeks. Additional subgroups of ZDF animals
received the above therapy starting at the age of 13 or
16 weeks, and continued until their sacrifice at 22 weeks.
The control (vehicle) groups of ZDF and ZL rats were
treated with 5% CM-Cellulose. Each group consisted of
at least 5 animals. We have recently reported that this dose
of Ebselen decreased the abundance of 3-nitrotyrosine-
modified proteins (the fingerprint of peroxynitrite for-
mation) in the plasma of ZDF rats at age of 22 weeks,
demonstrating that the therapeutic regimen used in
the study was pharmacologically valid and efficient
[24].
Prior to the sacrifice, rats were anesthetized with an
intraperitoneal injection of Ketamin-Xylazin (60 and
7.7 mg/kg body weight, respectively). A mid-laparotomy
was performed, the abdominal aorta was canulated with
P-50 catheter, and a mean blood pressure was measured
using a pressure monitor BP-1 (WPI). Subsequently,
blood was collected, and the kidneys were aseptically
removed. The right kidneys were used for angiogenesis
assays and for measurements of acetylcholine-induced
vasorelaxation, while the left kidneys were used for im-
munohistochemical analyses. Blood glucose (BG) con-
centration was measured using the modified Trinder color
reaction in accordance with the manufacturer’s protocol
(Raichem, San Diego, CA, USA). The serum concen-
trations of cholesterol and triglycerides were measured
by enzymatic/colorimetric methods using commercial as-
say kits; Wako Cholesterol CII and Wako L-Type TG H
test (Wako Chemicals USA, Inc., VA, USA). The animal
study protocol was approved by the institutional Animal
Care and Use Committee.
Ex vivo angiogenesis assay
The explants of freshly isolated renal cortex or medulla
(about 0.5 mm3) were placed in an ice-cold sterile EBM-
2 medium supplemented with EGM-2 kit (Clonetics,
Walkersville, MD, USA) containing 2% fetal bovine
serum, hEGF, VEGF, and IGF. All tissue samples
were rinsed three times with a fresh EBM-2 medium.
The explants were embedded in growth factor–depleted
Matrigel (Becton Dickinson, Rochester, NJ, USA) in cul-
ture chambers (Nalge Nunc, Int., NY, USA), as pre-
viously described [25, 26]. Sprouting cells have been
previously identified as predominantly endothelial, based
on their staining with endothelial cell markers, thus al-
lowing this widely used technique to be employed as an
angiogenic assay [25, 27]. Quantitative analysis of angio-
genesis in explant cultures was performed under an in-
verted fluorescence microscope (Nikon) equipped with a
CCD camera (Diagnostic Instruments, Sterling Heights,
MI, USA) relaying images to a monitor. Vascular sprouts
were counted daily along the perimeter of each sample
under ×150 magnification.
Histologic and immunohistochemical stainings
and analysis
Samples of renal tissue were fixed in a PLP solu-
tion (2% paraformaldehyde, 50 mmol/L lysine-HCl, and
10 mmol/L Na-m-periodate in PBS, pH 6.2) overnight at
4◦C, and embedded either in paraffin or in OCT com-
pound (Tissue-Tek, Torrance, CA, USA). The OCT com-
pound embedded samples were stored frozen at −80◦C.
Both paraffin and frozen samples were cut into 5-lm
thick sections. The following primary antibodies were
employed: mouse monoclonal anti-VEGF (C-1, corre-
sponding to amino acids 1–140 of human protein; 1:50
dilution), mouse monoclonal anti-Flk-1 (A-3; 1:100), goat
polyclonal anti-neuropilin-1 (C-19; 1:100) (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA), and rat en-
dothelial cell marker—mouse monoclonal anti-RECA-1
(1:40) (Cell Sciences, Inc., Canton, MA, USA). VEGF,
neuropilin-1, and RECA-1 stainings were visualized on
paraffin sections by indirect immunoperoxidase method
using LSAB+ system (DakoCytomation, Carpinteria,
CA, USA) in accordance with the manufacturer’s proto-
col. Antigen retrieval was accomplished by pretreatment
of sections with 0.1% tripsin in 0.1% CaCl2 for 15 minutes
at 37◦C for RECA-1 and microwave heating for 10 min-
utes in 10 mmol/L citric acid (pH 6.0) for neuropilin-1.
Flk-1–positive staining was visualized on frozen sec-
tions by immunofluorescence method using fluorescein
isothiocyanate (FITC) conjugated anti-mouse secondary
antibody (Jackson Immunoresearch Laboratories, Inc.,
West Grove, PA, USA). Unspecific protein binding was
blocked by 1 hour of incubation with 10% normal swine
serum followed by incubation with 1% bovine serum
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Table 1. Renal function and progression of metabolic syndrome in ZDF and ZL rats: Effect of Ebselen
ZL 8 weeks ZDF 8 weeks ZL 22 weeks ZL 22 weeks + E ZDF 22 weeks ZDF 22 weeks + E
Parameters (N = 7) (N = 7) (N = 10) (N = 5) (N = 10) (N = 9)
BW g 214 ± 9 332 ± 7a 358 ± 12 365 ± 16 432 ± 14b 410 ± 28∗∗
GFR mL/min 2.8 ± 0.2 2.6 ± 0.2 3.2 ± 0.2 2.8 ± 0.4 1.9 ± 0.4c 2.5 ± 0.3e
UPE mg/day 16.2 ± 0.6 32.9 ± 1.2 29.2 ± 2.7 23.9 ± 1.4 197.6 ± 15.7d 123.5 ± 11.2e
MBP mm Hg 105 ± 4 98 ± 12 103 ± 3 – 108 ± 5 101 ± 6
BG mg/dL 144 ± 16 198 ± 11a 181 ± 17 167 ± 15 400 ± 33d 395 ± 18d
TG mg/dL 35 ± 8 241 ± 41f 25 ± 13 30 ± 4 281 ± 23d 253 ± 43d
Cholesterol mg/dL 71 ± 8 115 ± 13 69 ± 6 68 ± 14 216 ± 26d 183 ± 17d
Abbreviations are: N, number of rats in each group; BW, body weight; GFR, glomerular filtration rate; UPE, urinary protein excretion; MBP, mean blood pressure;
BG, blood glucose; TG, triglycerides.
aP < 0.05 vs. ZL 8 weeks; bP < 0.05 vs. ZL 22 weeks and ZL 22 weeks + E; cP < 0.05 vs. ZL 22 weeks; dP < 0.001 vs. ZL 22 weeks and ZL 22 weeks + E; eP < 0.05
vs. ZDF 22 weeks; fP < 0.001 vs. ZL 8 weeks.
albumin (BSA) in PBS for 30 minutes. Controls included
omission of a primary antibodies and substitution of pri-
mary antibodies with the isotype-specific IgG. Sections
were counterstained with hematoxylin.
RECA-1 stained sections were employed for evalua-
tion of capillary density. The number of positively stained
peritubular capillary cross sections was counted sepa-
rately in the cortex and in the inner and outer medulla.
The capillary density was then expressed as a number
of RECA-positive capillaries per mm2 of section area.
At least 100 fields sized 0.54 mm2 were counted in each
area in at least 4 different animals per each group. Addi-
tionally, the number of positively stained capillary cross
sections was counted in at least 100 glomeruli for each
group, and glomerular capillary density was expressed
as a number of RECA-1–positive capillary sections per
glomerulus. Level of histopathologic damage was evalu-
ated in trichrome stained sections by counting lesions of
focal segmental glomerulosclerosis (FSGS) in 100 consec-
utive glomeruli for each kidney. Foci of tubulointerstitial
scars (TIS) were also counted in the same areas contain-
ing these 100 glomeruli. The level of FSGS was correlated
with the glomerular capillary density and the level of TIS
with the peritubular capillary density in the cortex.
Two different methods were employed to compare
VEGF, neuropilin-1, and Flk- immunostainings in ZL,
ZDF, and Ebselen treated ZDF rats. First, the intensity
of stainings in different kidney compartments was scored
from 0 to 3, with “0” indicating absence of staining, and
“3” indicating maximal staining intensity. The scoring of
samples was performed by two independent investigators
without knowledge of the source of renal sections. To re-
conform the results of semiquantitative scoring method,
multiple images of kidney sections were captured by dig-
ital imaging and submitted for image analysis by using
Adobe Photoshop 7.0 software. The kidney compart-
ments of interest were cropped, and the image complexity
was reduced using “Replace color” and “Color balance”
tools until all colors except for the specific staining were
substituted by black. The specific staining was then re-
placed by a primary color. Single color area was measured
with the Histogram tool using the same level range for ev-
ery measurement. A minimum of 12 images taken from
sections of 4 different animals in each group were used
for analysis of each staining in every kidney compartment
of interest. The results were expressed as a percentage of
specific staining per area of particular kidney compart-
ment.
Acetylcholine-induced vasorelaxation
Intralobar arteries were microdissected as previously
detailed [28]. Handled carefully to avoid damage, vessels
were mounted on wires in the chamber of a multivessel
myograph (J.P. Trading, Aarhus, Denmark) and bathed in
Kreb’s buffer. The medium was gassed with 95% O2–5%
CO2 and maintained at 37◦C (pH 7.4). After equilibra-
tion (30 min), the rings were set to an internal circumfer-
ence equivalent of 90% full relaxation under a transmural
pressure of 100 mm Hg, and were allowed to stabilize
for 20 to 30 minutes. The rings were then depolarized
with potassium chloride (KCl; 60 mmol/L) to evaluate
maximal contraction. After washing with Kreb’s buffer,
the vascular preparations were contracted with phenyle-
phrine (10−6 mol/L), and when the contractile response
was stabilized (steady-state phase, 12–15 min), vasorelax-
ing responses to cumulative increments in the concentra-
tion of acetylcholine or NONOate were examined [28].
Statistical analyses
The data were expressed as mean± SEM. The means of
two populations were compared by Student t test. To com-
pare means of several populations, one-way ANOVA was
used, followed by Tukey’s post-test for multiple compar-
isons. Correlation between two data sets was performed
using linear regression analysis, and Pearson r and two
tailed P values were calculated. Differences were consid-
ered significant when P < 0.05.
RESULTS
Validation of the experimental model
Parameters characterizing renal function and the pro-
gression of nephropathy and metabolic syndrome in ZDF
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Fig. 1. Capillary sprouting from explants of medulla (A and C) and cortex (B and D) of ZDF and ZL rats at 8 weeks (A and B) and 22 weeks (C
and D). Explants were embedded in matrigel lattices, and the number of sprouting capillaries was quantified daily, as detailed in Methods. Note
the high propensity for sprouting in explants from 8-week-old ZDF rats (A and B) and the suppression of sprouting in explants from 22-week-old
ZDF rats (C and D) compared to age-matched ZL rats. Chronic treatment with Ebselen was associated with the improved capillary sprouting in
explants from 22-week-old ZDF rats (C and D).
rats in comparison to ZL rats, as well as the effect of Eb-
selen on these parameters, are summarized in Table 1.
At the age of 8 weeks, ZDF rats were already obese and
exhibited mild hyperglycemia, but no proteinuria or im-
paired renal function was detected. The mean arterial
blood pressure, being within the normal range, was com-
parable to that of ZL rats. At 22 weeks, ZDF rats, in con-
trast to ZL rats, developed severe hyperglycemia, hyper-
triglyceridemia, hypercholesterolemia, proteinuria, and
decreased creatinine clearance. Mean arterial blood pres-
sure remained within normal range and was not different
between the groups.
Ebselen treatment changed neither the severity of the
diabetes nor the systemic blood pressure of the ZDF rats,
but significantly improved renal function. In ZL rats, no
significant effect of Ebselen on renal function, glycemia,
or blood pressure was observed.
Ex vivo angiogenic competence
The angiogenic competence of renal explants embed-
ded into matrigel lattices was evaluated by counting the
number of sprouting capillaries. At the age of 8 weeks,
both medullar and cortical (Fig. 1A and B, respectively)
explants from ZDF rats developed higher numbers of
capillary sprouts than explants from ZL rats (P < 0.01).
This relation was reversed after the onset of severe di-
abetes. As shown in Figure 1 (C, medulla and D, cor-
tex), a significantly lower number of capillary sprouts
were detectable in explants from 22-week-old ZDF rats
compared to explants from age-matched ZL rats (P <
0.01). Treatment of ZDF rats with Ebselen significantly
improved capillary sprouting from medullar and cortical
explants (Fig. 1C and D, respectively), suggesting that the
angiogenic competence of renal explants can be partially
restored by peroxynitrite scavenging.
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Fig. 2. Capillary density in different renal compartments of ZL, ZDF, and Ebselen treated ZDF rats. RECA-labeled endothelial cells in glomeruli
of 8- and 22-week-old ZDF and ZL rats (A). Right panels represent images of RECA-stained capillaries in each corresponding compartment.
Original magnification was ×400. ∗P < 0.001 vs. ZL 22 weeks; ∗∗P < 0.05 vs. ZL and ZDF 22 weeks; ∗∗∗P < 0.001 vs. ZL 22 weeks, and P < 0.01 vs.
ZDF + E, 9-22 weeks. Peritubular capillary density in cortex of 8- and 22-week-old ZDF and ZL rats (B). ∗P < 0.05 vs. ZDF 8 weeks; ∗∗P < 0.01
vs. ZDF 22 weeks, and P < 0.05 vs. ZDF + E, 13-22 weeks. Capillary density in the outer medulla of 8- and 22-week-old ZDF and ZL rats (C). ∗P
< 0.001 vs. ZL 22 weeks, and P < 0.05 vs. ZDF + E, 9-22 weeks. Capillary density in the inner medulla of 8- and 22-week-old ZDF and ZL rats (D).
∗P < 0.001 vs. ZDF 8 weeks; ∗∗P < 0.01 vs. ZDF 22 weeks, and vs. ZDF + E, 13-22 weeks; ∗∗∗P < 0.05 vs. ZDF 22 weeks, and vs. ZDF + E, 13-22
weeks.
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Fig. 4. Immunodetectable VEGF in the blood vessels and podocytes of ZL, ZDF, and Ebselen treated ZDF rats. Representative images of VEGF
staining in 8-week-old rats showing higher intensity of the staining in the blood vessels of ZDF (B) compared to ZL (A). Negative control (C):
section of 22-week-old Ebselen treated ZDF rat incubated with the isotype-specific IgG instead of primary antibody. Representative images of
VEGF staining in 22-week-old rats showing reduced intensity of the staining in the blood vessels of ZDF (E) compared to ZL (D), and restoration
of VEGF staining in Ebselen treated ZDF rats (F). Representative images of VEGF staining in cortical tubules and glomeruli of 22-week-old ZL
(G), ZDF (H), and Ebselen treated ZDF (I) rats showing similar level of staining in all 3 groups. Original magnification for all micrographs was
×400. (J to L) Enlarged images of the glomeruli from micrographs G to I showing localization of VEGF staining in podocytes. Summary of digital
image analysis of VEGF expression in glomeruli (M), blood vessels (N), cortical (O), and medulla tubules (P) in ZL, ZDF, and Ebselen treated
ZDF rats. Level of positive VEGF immunostaining in smooth muscle cells surrounding the blood vessels was significantly increased in ZDF rats by
the age of 8 weeks, but decreased by 22 weeks in comparison to age-matched ZL rats. Chronic treatment with Ebselen ameliorated the decrease in
VEGF staining intensity in 22-week-old ZDF rats. ∗P < 0.05 vs. 8-week-old ZDF, and ∗∗P < 0.05 vs. 22-week-old ZL, ZL + E, and ZDF + E.
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Table 2. Quantification of VEGF staining
ZL 22 weeks + E, ZDF 22 weeks + E, ZDF 22 weeks + E,
Kidney area ZL 8 weeks ZDF 8 weeks ZL 22 weeks ZDF 22 weeks 9–22 weeks 9–22 weeks 13–22 weeks
Podocytes 0.1 ± 0.1 0.25 ± 0.1 0.25 ± 0.1 0.37 ± 0.2 0.12 ± 0.1 0.31 ± 0.16 0.12 ± 0.1
BV 0.02 ± 0.01 0.2 ± 0.03a 0.68 ± 0.1 0.31 ± 0.1b 0.53 ± 0.08 1.02 ± 0.2c 0.19 ± 0.06
PT 0.02 ± 0.01 0.37 ± 0.1a 0.5 ± 0.3 1.12 ± 0.37 1.25 ± 0.25 1.37 ± 0.37 0.75 ± 0.25
CDT and CCD 0.75 ± 0.1 1 ± 0.19 2 ± 0.16 1.31 ± 0.21 1.25 ± 0.32 1.65 ± 0.12 0.75 ± 0.25
MCD 0.31 ± 0.06 0.31 ± 0.06 1.25 ± 0.32 0.25 ± 0.1b 0.75 ± 0.75 0.62 ± 0.29 0.75 ± 0.75
THAL 1.18 ± 0.31 1 ± 0.2 1.87 ± 0.12 2 ± 0.35 0.87 ± 0.62 1.81 ± 0.27 1.5 ± 0
Abbreviations are: BV, blood vessels; PT, proximal tubules; CDT, cortical distal tubules; CCD, cortical collecting ducts; MCD, medullar collecting ducts; THAC,
thick ascending limbs.
aP < 0.0001 vs. ZL 8-week-ol; bP < 0.05 vs. ZL 22-week-old; cP < 0.01 vs. ZDF 22-week-old.
Table 3. Quantification of Flk-1 staining
ZL 22 weeks + E, ZDF 22 weeks + E, ZDF 22 weeks + E,
Kidney area ZL 8 weeks ZDF 8 weeks ZL 22 weeks ZDF 22 weeks 9–22 weeks 9–22 weeks 13–22 weeks
PC 1.56 ± 0.6 2 ± 0.35 1.5 ± 0.35 1 ± 0.45 1.62 ± 0.45 1.25 ± 0.4 1.62 ± 0.15
BV 0.98 ± 0.26 1.02 ± 0.16 1.25 ± 0.18 0.78 ± 0.28a 0.67 ± 0.19 1.5 ± 0.25b 0.91 ± 0.16
PC, peritubular capillaries; BV, blood vessels.
aP < 0.05 vs. ZL 22-week-old; bP < 0.05 vs. ZDF 22-week-old.
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Fig. 3. Correlation of the capillary density with the level of histopatho-
logic damage in ZL, ZDF, and Ebselen treated ZDF rats. Number of
foci of TIS negatively correlates with the cortical peritubular capillary
density (A). The severity of FSGS negatively correlates with the capil-
lary density in glomeruli (B).
In vivo angiogenic competence
Differences in capillary density between experimental
groups were assessed separately in the cortex, the outer
medulla, the inner medulla, and the glomeruli by count-
ing RECA-1–positive cells, as detailed in Methods. Rep-
resentative images of RECA-1 staining and the quantita-
tive summary of their density in glomeruli, cortex, outer
medulla, and inner medulla are shown in Figure 2 (A to
D). At the age of 8 weeks, capillary density was signif-
icantly higher in the cortex (Fig. 2B) and in the inner
medulla (Fig. 2D) of ZDF rats than in the age-matched
ZL rats. Consistent with the data on ex vivo angiogenic
competence of renal explants, by the age of 22 weeks,
the diabetic rats developed a marked dropout of renal
microvessels. As summarized in Figure 2A, B, and D,
capillary density was significantly lower in glomeruli, cor-
tex, and inner medulla of 22-week-old ZDF rats as com-
pared to age-matched ZL rats. The dropout of capillaries
was partially prevented in ZDF rats treated with Ebse-
len starting at week 9 (Fig. 2A and D). However, if the
treatment was started later, at week 13, there was no sig-
nificant prevention of capillary dropout. Importantly, the
capillary dropout in 22-week-old ZDF rats and its partial
prevention by Ebselen showed a strong negative corre-
lation with the degree of histopathologic damage char-
acterized by the presence of FSGS lesions (Fig. 3A) and
foci of TIS (Fig. 3B).
To test the hypothesis that altered expression of VEGF
system components contributes to the observed mi-
crovascular rarefaction, we next examined the expression
of VEGF and its receptors. Positive staining with anti-
VEGF antibodies was observed and scored separately in
podocytes, blood vessels, proximal tubules, cortical col-
lecting duct and distal tubules, medullar collecting duct,
and thick ascending limb. As summarized in Table 2 and
illustrated by Figure 4, positive VEGF staining was ob-
served in podocytes and in smooth muscle cells of blood
vessels, as well as in tubular epithelial cells. As shown
by scoring and by digital image analysis, the intensity of
VEGF staining in blood vessels was higher in ZDF rats
than in ZL rats at 8 weeks of age (Fig. 4B vs. A), but lower
by 22 weeks (Fig. 4D vs. C), and was significantly im-
proved (P < 0.05) in ZDF rats treated with Ebselen dur-
ing 9- to 22-week period (Fig. 4E). The intensity of VEGF
staining in other kidney compartments showed incon-
sistent patterns of changes. Positive anti-Flk-1 staining
was observed and analyzed in glomerular and peritubular
capillary endothelial cells, as well as in endothelial cells
of larger blood vessels (Fig. 5 and Table 3). Interestingly,
the intensity of Flk-1 staining was significantly decreased
in blood vessels of 22-week-old ZDF rats (P < 0.05 vs.
age-matched ZL, Fig. 5B vs. A), and restored in Ebselen-
treated group (P < 0.05 vs. 22-week-old ZDF, Fig. 5C).
Positive neuropilin-1 staining was observed and analyzed
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Fig. 5. Immunodetectable Flk-1 in ZL, ZDF, and Ebselen treated ZDF rats. Representative images of immunofluorescent Flk-1 staining in glomeruli
(A), inner medulla peritubular capillaries (B), and blood vessels of 22-week-old ZL, ZDF, and Ebselen treated ZDF rats, showing decrease in staining
intensity in endothelial cells layer of blood vessels in 22-week-old ZDF rats (D) compared to age-matched ZL (C), and restoration of the staining
intensity in Ebselen treated ZDF group (E). Original magnification was ×600. Representative images of Western blot analysis of kidney lysates from
ZL and ZDF rats show presence of 207K bends corresponding to the expected molecular weight of Flk-1 (F). Summary of digital image analysis
of Flk-1 immunofluorescence in glomeruli (G), inner medulla peritubular capillaries (H), and blood vessels of ZL, ZDF and Ebselen treated ZDF
rats (I), showing significant decrease in immunofluorestent intensity of the staining in 22-week-old ZDF rats, compared to age-matched ZL, and
restoration of the staining in Ebselen treated ZDF rats. ∗P < 0.01 vs.22-week-old ZL, and ZL + E, and P < 0.05 vs. ZDF + E.
in glomeruli, cortical and medullar tubular epithelial cells,
and inner and outer medulla peritubular capillaries (Fig. 6
and Table 4). As shown by semiquantitative scoring, the
intensity of neuropilin-1 staining was markedly decreased
in glomeruli, cortex, and in inner and outer medulla per-
itubular capillaries of 22-week-old ZDF rats (Table 4).
Digital image analysis of neuropilin-1 immunostaining
showed significant decrease in the intensity of the staining
in 22-week-old ZDF rats, as compared with age-matched
ZL only in the inner medulla peritubular capillaries, but
not in other kidney compartments (Fig. 6I). In ZDF rats
treated with Ebselen, intensity of neuropilin-1 staining
was similar to that observed in age-matched ZL rats
(Fig. 6F vs. D).
Vascular reactivity to acetylcholine
Since angiogenesis may be impaired if the endothe-
lium is dysfunctional, we next sought to assess endothe-
lial function in the renal resistance arteries of ZDF rats.
It has been established that one of the key parame-
ters characterizing endothelial dysfunction is the impair-
ment of endothelium-dependent vasorelaxation [29, 30].
Endothelium-dependent vasorelaxation of intralobar ar-
teries is mediated by both nitric oxide and endothelium-
derived hyperpolarizing factor [28]. Renal intralobar
arteries were microdissected and studied, as described in
Methods. Specifically, preconstricted arteries were stim-
ulated with escalating doses of acetylcholine, and the cu-
mulative dose-response curve was obtained. As shown
in Figure 7A, responsiveness to acetylcholine was intact
in microdissected intralobar arteries of 8-week-old ZDF
rats compared to age-matched ZL. Intralobar arteries mi-
crodissected from 22-week-old ZDF rats exhibited a pro-
found defect of acetylcholine-induced vasorelaxation at
all concentration tested (Fig. 7D). This defect was almost
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 6. Immunodetectable neuropilin-1 in the glomeruli and inner medulla of ZL, ZDF, and Ebselen treated ZDF rats. (A to C) Representative
images of glomeruli expression of neuropilin-1 in 22-week-old rats showing higher intensity of staining in ZL and Ebselen treated ZDF rats compared
to untreated ZDF rats. Representative images of neuropilin-1 staining showing higher intensity of the staining in inner medulla in 22-week-old
ZL (D) and Ebselen treated ZDF (F) rats compared to untreated ZDF group (E). The inserts show neutropilin-1 staining in medulla peritubular
capillaries. Original magnification was ×600. Representative examples of Western blot analysis of neuropilin-1 in kidney lysates of ZL and ZDF
rats showing presence of 123 K bends corresponding to expected molecular weight of neuropilin-1 (G). Summary of digital image analysis of
neuropilin-1 immunostaining in glomeruli (H) and inner medulla peritubular capillaries (I), showing statistically significant decrease in the staining
intensity in inner medulla peritubular capillaries of 22-week-old ZDF rats, and restoration of the staining in Ebselen treated ZDF, as compared
with age-matched ZL rats. ∗P < 0.05 vs. 22-week-old ZL, ZL + E, and ZDF + E.
completely prevented by Ebselen treatment. To evalu-
ate the contribution of endothelium-derived nitric ox-
ide to relaxation, experiments were repeated after inhi-
bition of nitric oxide synthase with L-NAME (Fig. 7B
and E). This pretreatment resulted in a dramatic loss
of acetylcholine-induced relaxation in microdissected in-
tralobar arteries of 8-week-old ZL and ZDF rats and 22-
week-old ZL controls, while vessels from 22-week-old
ZDF rat showed a complete loss of relaxation. These find-
ings strongly suggest that acetylcholine-induced NO gen-
eration is severely impaired in 22-week-old ZDF rats. To
evaluate the endothelium-independent component of re-
laxation, in the next series of experiments, preconstricted
vessels were treated with a nitric oxide donor NONOate.
As depicted in Figure 7C and D, this NO donor elicited
relaxation comparable in all groups, suggesting that vas-
cular smooth muscle reactivity to NO was not significantly
impaired in ZDF rats.
DISCUSSION
The data presented herein provide complementary
ex vivo and in vivo evidence for the impaired angio-
genesis in the model of metabolic syndrome and type
2 diabetes–Zucker diabetic fatty (fa/fa) rat. The pro-
gression of nephropathy in these animals was accom-
panied by the rarefaction of capillary profiles, in stark
contrast to the early increase in their density. There
exists a remarkable correlation of ex vivo angiogenic
competence with the above in vivo results—matrigel-
embedded explants obtained from the kidneys of ZDF
rats at age of 8 weeks showed increased angiogenic com-
petence, whereas at the age of 22 weeks capillary sprout-
ing was significantly suppressed. Although these findings
do not provide an unequivocal answer to the question of
the primacy of glomerular or tubulointerstitial vis-a-vis
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Table 4. Quantification of neuropilin staining
ZL 22 w + E, ZDF 22 w + E, ZDF 22 w + E,
Kidney area ZL 8 w ZDF 8 w ZL 22 w ZDF 22 w 9–22 w 9–22 w 13–22 w
Glomeruli 0.15 ± 0.06 0.13 ± 0.06 2.34 ± 0.14 1.11 ± 0.1b 2.28 ± 0.25d 2.10 ± 0.20c 2.12 ± 0.24d
Cortex 0.13 ± 0.07 0.14 ± 0.06 2.14 ± 0.12 1.15 ± 0.24a 2.33 ± 0.25c 1.94 ± 0.13c 1.94 ± 0.13c
OMPC 0.22 ± 0.11 0.18 ± 0.07 1.53 ± 0.18 1.25 ± 0.18 1.51 ± 0.21 1.45 ± 0.15 1.55 ± 0.13
IMPC 0.21 ± 0.10 0.19 ± 0.08 2.82 ± 0.13 1.26 ± 0.21a 2.62 ± 0.09c 2.05 ± 0.21c 1.89 ± 0.11
OMPC, outer medulla peritubular capillaries; IMPC, inner medulla peritubular capillaries.
aP < 0.01 vs. ZL 22-week-old; bP < 0.001 vs. ZL 22-week-old; cP < 0.05 vs. ZDF 22-week-old; dP < 0.01 vs. ZDF 22-week-old.
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Fig. 7. Vascular reactivity of microdissected intralobar arteries in 8- and 22-week-old ZL, ZDF, and Ebselen treated ZDF rats. Cumulative dose-
response curve to application of acetylcholine without (A) and with (B) pretreatment with L-NAME in 8-week-old ZDF and ZL rats. Cumulative
dose-response to a nitric oxide donor NONOate in 8-week-old ZDF and ZL rats (C). Cumulative dose-response curve to application of acetylcholine
without (D) and with (E) pretreatment with L-NAME in 22-week-old ZL, ZDF, and Ebselen treated ZDF rats. ∗P < 0.01 vs. ZL and ZDF + E,
#P < 0.05 vs. ZDF and ZDF + E. Cumulative dose-response to a nitric oxide donor NONOate in 22-week-old ZL, ZDF, and Ebselen treated ZDF
rats (F).
microvascular mechanism in the progression, the data
offer several insights into angiogenic competence in this
model of metabolic syndrome.
In the present experiments, angiogenesis from the ex-
plants of the renal parenchyma (hence, deprived of the
circulating pro- and anti-angiogenic cues specific for in
vivo processes) showed a notable similarity to the angio-
genic competence observed in vivo in the kidneys of ZDF
rats, namely, the age-dependent stimulation and suppres-
sion of angiogenesis at 8 and 22 weeks, respectively.
Such a complementarity would argue that local, tissue-
specific factors provide the most significant impact on
angiogenic competence. This phenomenon could be due
to the “memory” effect of the endothelium in diabetes
[31], or to the specific characteristics of the extracellular
matrix present in the explanted tissues, like accumula-
tion of AGE-modified proteins with the extended half-
life. A number of growth factors capable of modulating
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angiogenesis are deposited in the extracellular matrix
(i.e., VEGF, TGF-beta, endostatin, to name a few). Since
all explants were cultured in the medium containing sup-
plemental VEGF, it is unlikely that the observed differ-
ences in ex vivo angiogenesis were secondary exclusively
to the perturbations of VEGF synthesis or expression.
Our previous studies [18] provided evidence that nonen-
zymatically glycated long-lived matrix proteins modify
the ability of endothelial cells to form capillary tubes by
reducing their branching angiogenesis. Hence, it is possi-
ble that long-lived extracellular matrix proteins modified
by nonenzymatic glycation, present in the explants and in
the in vivo kidneys, could have contributed to the devel-
opment of angiogenic incompetence in both. This expla-
nation, however, does not pertain to the early induction
of angiogenesis in vivo and ex vivo. This early induction
of angiogenesis may be the result of hyperinsulinemia
present in young ZDF rats. Indeed, it has been demon-
strated that insulin, like hypoxia, induces VEGF [32].
The above mechanism may explain the observed pseudo-
hypoxic stimulation of angiogenesis in young ZDF rats.
Changes in VEGF were biphasic: the early small in-
crease followed by the late decline in its abundance. Our
findings are in agreement with observations by Cooper et
al [33] demonstrating increased VEGF in the early stages
of streptozotocin diabetes. Unfortunately, no measure-
ments of capillary density were performed in that study.
This finding could provide an explanation to the obser-
vation that antibodies against VEGF improved the early
diabetic nephropathy [34]. Similar events occurred in our
ZDF rats.
The observed changes in VEGF expression and an-
giogenesis defy the existing physiologic paradigm that
hypoxia and hypoglycemia stimulate VEGF expression,
whereas hyperoxia suppresses it. What is actually tak-
ing place in the course of progressive nephropathy in
ZDF rats is in part the opposite: initially, hyperglycemia
causes stimulation of VEGF expression (pseudo-hypoxic
effect referred to above and putatively linked to hyper-
insulinemia), but later VEGF expression is suppressed
(pseudo-hyperoxic effect). In both cases capillary den-
sity reflects the state of VEGF expression. Understand-
ing this paradigm shift in metabolic syndrome and type
2 diabetes may have profound implications in preventing
progressive nephropathy.
There is growing evidence for developing mitochon-
drial dysfunction in the course of diabetes [31]. We have
previously demonstrated that mitochondrial superoxide
production is increased in endothelial cells exposed to
D-glucose (but not to the equimolar L-glucose) with the
attendant reduction in mitochondrial NO generation in
endothelial cells [36]. Consequently, this may lead to
the increased oxygen consumption by the endothelium,
resulting in the further exacerbation of oxidative stress
and endothelial dysfunction. The above mechanism may
provide a putative explanation for the observed pseudo-
hyperoxic responses: suppression of VEGF and impaired
angiogenesis. In this context, endothelial dysfunction
may serve as a critical modifier of angiogenic responses.
Indeed, 22-week-old ZDF rats develop endothelial
dysfunction, as judged from the vascular responses
to acetylcholine. Acetylcholine elicited “normal”
endothelium-dependent vasorelaxation of intralobar
arteries of 7- to 8-week-old ZDF rats, but almost com-
pletely failed to elicit relaxation at the age of 22 weeks.
Endothelium-dependent vasorelaxation is considered to
be the most reliable marker of endothelial dysfunction
[7, 29, 30]. We have previously demonstrated that inhi-
bition of endothelial nitric oxide synthase, a condition
recapitulating many features of endothelial dysfunction,
resulted in a decreased migration, wound healing, and
angiogenesis [4–6]. Angiogenesis in eNOS knockout
mice was similarly impaired [37], as was their ability to
form collateral vessels after the ligation of the femoral
artery. These and other data provide a solid foundation
to the notion that the dysfunctional endothelium is
unable to engage in angiogenic remodeling even in
the presence of a gradient of guidance cues. From this
standpoint, we have previously demonstrated that the
macrovascular endothelium in ZDF rats is dysfunctional
[19]. The present data obtained in intralobar arteries
expand this conclusion to the microvascular bed—
acetylcholine-induced vasorelaxation, a classic indicator
of endothelium-dependent function that is perturbed
early in the course of developing dysfunction [29, 30], was
severely depressed in ZDF rats. For technical reasons,
such an analysis could not be expanded to the smaller cal-
iber vessels. The above failure of vasorelaxation signifies
defective NO production or bioavailability, conditions
associated with the profound changes in both VEGF
expression and angiogenic competence [38]. In addition
to this NO-dependent mechanism, the actual in vivo
causes of angiogenic incompetence in ZDF rats should
be even more complex due to the impaired expression
of VEGF receptors. The finding that Ebselen improves
endothelial dysfunction and, in parallel, restores VEGF
expression and angiogenic competence supports the
above scenario implicating mitochondrial oxidative
stress in the impaired orchestration of angiogenesis.
Collectively, these findings further the concept on the
role of VEGF in the pathogenesis of renal fibrosis [39]
by adding a further layer of complexity—endothelial
dysfunction, as a potent modifier of angiogenic response.
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